Szerző: " Paz-Ares Luis"

Paz-Ares Luis; Dvorkin Mikhail; Chen Yuanbin; Reinmuth Niels; Hotta Katsuyuki; Trukhin Dmytro; Statsenko Galina; Hochmair Maximilian J; Özgüroğlu Mustafa; Ji Jun Ho; Voitko Oleksandr; Poltoratskiy Artem; Ponce Santiago; Verderame Francesco; Havel Libor; Bondarenko Igor; Kazarnowicz Andrzej; Losonczy György; Conev Nikolay V; Armstrong Jon; Byrne Natalie; Shire Norah; Jiang Haiyi; Goldman Jonathan W; Kollaborációs szervezet: CASPIAN investigators; Somfay Attila; et al.: Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN) : a randomised, controlled, open-label, phase 3 trial.
LANCET, 394 (10212). pp. 1929-1939. ISSN 0140-6736 (2019)

Ciuleanu Tudor; Socinski Mark A; Obasaju Coleman; Luft Alexander V; Szczesna Aleksandra; Szafranski Wojciech; Ramlau Rodryg; Bálint Beatrix; Molinier Olivier; Depenbrock Henrik; Nanda Shivani; Paz-Ares Luis; Thatcher Nick: Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
CLINICAL LUNG CANCER, 19 (2). 130-138.e2. ISSN 1525-7304 (2018)

Paz-Ares Luis; Bálint Beatrix; de Boer Richard H; van Meerbeeck Jan P; Wierzbicki Rafal; De Souza Paul; Galimi Francesco; Haddad Vincent; Sabin Tony; Hei Yong-jiang; Pan Yang; Cottrell Susan; Hsu Cheng-Pang; RamLau Rodryg: A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer.
JOURNAL OF THORACIC ONCOLOGY, 8 (3). pp. 329-337. ISSN 1556-0864 (2013)